-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Vir Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q2 2025.
- Vir Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $12.5M, a 43.8% decline year-over-year.
- Vir Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $59M, a 41.6% decline year-over-year.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $78.5M, a 29.5% decline from 2023.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $111M, a 9.05% increase from 2022.
- Vir Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $102M, a 21.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)